Early On emphasizes early identification and early referral to minimize delays and maximize developmental outcomes. Understanding your child's development may help you recognize if your …

Early On Michigan is an early intervention program for children who need extra support and help because they have a development delay or pre-existing health issues that could slow their …

After a young child (birth to 3) is found eligible for early intervention services, a team (including the parents, professionals and your service coordinator) meets to develop the Individualized Family …

Boehringer Ingelheim supports different kinds of Early Access Treatments. Programs like Compassionate Use and Expanded Access in addition to single patient requests, are an important …

Early Access Programs allow patients and physicians to use investigational (pre-approval) drugs outside the clinical trial setting. They are often referred to as Expanded Access Programs (EAPs), …

Michigan’s Early On program, led by the Michigan Department of Lifelong Education, Advancement, and Potential (MiLEAP), is a statewide early intervention system that provides services for families with …

Early access is a potential pathway for patients diagnosed with a serious and/or life-threatening disease or condition to gain access to an investigational drug for treatment outside of a clinical trial when no …

Early access programs are a means by which investigational therapies are made available, in certain circumstances, to treat patients with serious diseases who are unable to participate in an ongoing …

Healthcare professionals often seek to access these medicines for their patients, and biopharmaceutical companies developing innovative medicines are increasingly making these medicines available to …

Early access programs are crafted to grant patients grappling with life-threatening unmet medical needs or diseases access to promising treatments that haven't yet garnered marketing approval.